And more spindle shaped. Similar morphological changes are, for example, alsoAnd more spindle shaped. Similar

May 22, 2018

And more spindle shaped. Similar morphological changes are, for example, also
And more spindle shaped. Similar morphological changes are, for example, also observed with fibroblasts upon transformation by SFK. Click here PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/25957400 for file [http://www.biomedcentral.com/content/supplementary/1478811X-6-7-S1.ppt] 1. 2. 3. 4. Summy JM, Gallick GE: Src family kinases in tumor progression and metastasis. Cancer Metastasis Rev 2003, 22:337-358. Martin GS: The hunting of the Src. Nat Rev Mol Cell Biol 2001, 2:467-475. Johnson FM, Gallick GE: SRC family nonreceptor tyrosine kinases as molecular targets for cancer therapy. Anticancer Agents Med Chem 2007, 7:651-659. Wood LD, Parsons DW, Jones S, Lin J, Sjoblom T, Leary RJ, Shen D, Boca SM, Barber T, Ptak J, Silliman N, Szabo S, Dezso Z, Ustyanksky V, Nikolskaya T, Nikolsky Y, Karchin R, Wilson PA, Kaminker JS, Zhang Z, Croshaw R, Willis J, Dawson D, Shipitsin M, Willson JK, Sukumar S, Polyak K, Park BH, Pethiyagoda CL, Pant PV, et al.: The genomic landscapes of human breast and colorectal cancers. Science 2007, 318:1108-1113. Emaduddin M, Bicknell DC, Bodmer WF, Feller SM: Cell growth, global phosphotyrosine elevation, and c-Met phosphorylation through Src family kinases in colorectal cancer cells. Proc Natl Acad Sci USA 2008, 105:2358-2362. Kopetz S, Shah AN, Gallick GE: Src continues aging: current and future clinical directions. Clin Cancer Res 2007, 13:7232-7236. Mayer BJ, Hirai H, Sakai R: Evidence that SH2 domains promote processive phosphorylation by protein-tyrosine kinases. Curr Biol 1995, 5:296-305. Songyang Z, Shoelson SE, Chaudhuri M, Gish G, Pawson T, Haser WG, King F, Roberts T, Ratnofsky S, Lechleider RJ, Neel BG, Birge RB, Fajardo JE, Chou MM, Hanafusa H, Schaffhausen B, Cantley LC: SH2 domains recognize specific phosphopeptide sequences. Cell 1993, 72:767-778. Collette Y, Lasalocid (sodium) mechanism of action Dutartre H, Benziane A, Ramos M, Benarous R, Harris M, Olive D: Physical and functional interaction of Nef with Lck. HIV-1 Nef-induced T-cell signaling defects. J Biol Chem 1996, 271:6333-6341. Wu H, Reynolds AB, Kanner SB, Vines RR, Parsons JT: Identification and characterization of a novel cytoskeleton-associated pp60src substrate. Mol Cell Biol 1991, 11:5113-5124. Sefton BM, Hunter T, Ball EH, Singer SJ: Vinculin: a cytoskeletal target of the transforming protein of Rous sarcoma virus. Cell 1981, 24:165-174. Valgeirsdottir S, Claesson-Welsh L, Bongcam-Rudloff E, Hellman U, Westermark B, Heldin CH: PDGF induces reorganization of vimentin filaments. J Cell Sci 1998, 111(Pt 14):1973-1980.5.6.Additional FileSupplementary Table. Click here for file [http://www.biomedcentral.com/content/supplementary/1478811X-6-7-S2.xls]7. 8.9.10. 11. 12.Page 10 of(page number not for citation purposes)Cell Communication and Signaling 2008, 6:http://www.biosignaling.com/content/6/1/13.14. 15. 16. 17. 18.19. 20. 21.22.23.24. 25.26. 27.28. 29.30.31.32.Foucault I, Le Bras S, Charvet C, Moon C, Altman A, Deckert M: The adaptor protein 3BP2 associates with VAV guanine nucleotide exchange factors to regulate NFAT activation by the B-cell antigen receptor. Blood 2005, 105:1106-1113. Yin G, Zheng Q, Yan C, Berk BC: GIT1 is a scaffold for ERK1/2 activation in focal adhesions. J Biol Chem 2005, 280:27705-27712. Zhang J, Suzuki K, Hitomi T, Siraganian RP: TOM1L1 is a Lyn substrate involved in FcepsilonRI signaling in mast cells. J Biol Chem 2007, 282:37669-37677. Xu J, Bai XH, Lodyga M, Han B, Xiao H, Keshavjee S, Hu J, Zhang H, Yang BB, Liu M: XB130, a novel adaptor protein for signal transduction. J Biol Chem 2007, 282:16401-.